GSK Gross Profit 2010-2022 | GSK

GSK annual/quarterly gross profit history and growth rate from 2010 to 2022. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • GSK gross profit for the quarter ending June 30, 2022 was $5.967B, a 22.91% decline year-over-year.
  • GSK gross profit for the twelve months ending June 30, 2022 was $30.543B, a 4.11% increase year-over-year.
  • GSK annual gross profit for 2021 was $30.955B, a 7.65% increase from 2020.
  • GSK annual gross profit for 2020 was $28.755B, a 2.87% increase from 2019.
  • GSK annual gross profit for 2019 was $27.953B, a 1.76% increase from 2018.
GSK Annual Gross Profit
(Millions of US $)
2021 $30,955
2020 $28,755
2019 $27,953
2018 $27,470
2017 $25,575
2016 $25,207
2015 $23,042
2014 $25,847
2013 $28,041
2012 $29,383
2011 $32,176
2010 $32,163
2009 $32,865
GSK Quarterly Gross Profit
(Millions of US $)
2022-06-30 $5,967
2022-03-31 $8,172
2021-12-31 $7,872
2021-09-30 $8,533
2021-06-30 $7,741
2021-03-31 $6,810
2020-12-31 $7,345
2020-09-30 $7,442
2020-06-30 $6,422
2020-03-31 $7,546
2019-12-31 $7,313
2019-09-30 $7,571
2019-06-30 $6,650
2019-03-31 $6,419
2018-12-31 $4,201
2018-09-30 $7,109
2018-06-30 $6,805
2018-03-31 $9,355
2017-12-31 $6,734
2017-09-30 $6,796
2017-06-30 $6,012
2017-03-31 $6,034
2016-12-31 $6,311
2016-09-30 $6,589
2016-06-30 $6,325
2016-03-31 $5,869
2015-12-31 $5,757
2015-09-30 $6,081
2015-06-30 $5,949
2015-03-31 $5,324
2014-12-31 $6,090
2014-09-30 $6,063
2014-06-30 $6,574
2014-03-31 $6,555
2013-12-31 $7,173
2013-09-30 $7,246
2013-06-30 $7,137
2013-03-31 $6,804
2012-12-31 $7,555
2012-09-30 $7,224
2012-06-30 $7,055
2012-03-31 $7,874
2011-12-31 $8,004
2011-09-30 $8,083
2011-06-30 $8,267
2011-03-31 $7,670
2010-12-31 $8,371
2010-09-30 $7,606
2010-06-30 $6,724
2010-03-31 $8,238
2009-12-31 $9,776
2009-09-30 $8,171
2009-06-30 $7,907
2009-03-31 $7,164
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $59.851B $46.910B
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $151.795B 9.21
Bio-Rad Laboratories (BIO.B) United States $12.433B 27.47
Biohaven Pharmaceutical Holding (BHVN) United States $10.831B 0.00
QIAGEN (QGEN) Netherlands $9.374B 15.70
Ginkgo Bioworks Holdings (DNA) United States $5.569B 0.00
Arcus Biosciences (RCUS) United States $1.888B 36.85
Myovant Sciences (MYOV) United Kingdom $1.723B 0.00
Emergent Biosolutions (EBS) United States $1.047B 6.07
ADC Therapeutics SA (ADCT) Switzerland $0.370B 0.00
Zymeworks (ZYME) Canada $0.356B 0.00
Enzo Biochem (ENZ) United States $0.109B 0.00
Gelesis Holdings (GLS) United States $0.078B 0.00
SQZ Biotechnologies (SQZ) United States $0.067B 0.00
Ambrx Biopharma (AMAM) United States $0.042B 0.00